<DOC>
	<DOCNO>NCT02104076</DOCNO>
	<brief_summary>The Evolution® Biliary Stent System-Fully Covered study clinical trial approve US FDA evaluate effectiveness Evolution® Biliary Stent System-Fully Covered use palliation malignant neoplasms biliary tree .</brief_summary>
	<brief_title>Evolution® Biliary Stent System-Fully Covered</brief_title>
	<detailed_description />
	<criteria>Inoperable malignant neoplasm cause biliary obstruction stricture require fully cover metal stent &lt; 18 year age Unwilling unable sign date inform consent Unwilling unable comply followup schedule Undergone planning undergo brachytherapy transpapillary percutaneous implantation intracavitary radiation source Participating another investigational drug device study patient complete followup phase primary endpoint least 30 day prior enrollment Endoscopic procedure contraindicate Current anatomy upstream intend stent placement compromise flow bile liver stent placement may alleviate biliary obstruction symptom Presence metal biliary stent Presence esophageal duodenal stent Hypersensitivity/allergy contraindication component stent , delivery system , medication require complete procedure , investigator 's opinion adequately premedicated Coagulopathy Diffuse intrahepatic metastasis involve &gt; 10 % liver Life expectancy &lt; 3 month Pregnant Active alcohol substance abuse issue Jaundice secondary cause biliary duct obstruction Additional endoscopic restriction specify Clinical Investigation Plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bile Duct Obstructions</keyword>
	<keyword>Biliary Stases</keyword>
	<keyword>Biliary Tract</keyword>
	<keyword>Stents</keyword>
</DOC>